1. Home
  2. BAFN vs ICCM Comparison

BAFN vs ICCM Comparison

Compare BAFN & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$8.00

Market Cap

40.6M

Sector

Finance

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.69

Market Cap

45.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
ICCM
Founded
1999
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
45.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BAFN
ICCM
Price
$8.00
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
5.9K
400.3K
Earning Date
10-30-2025
11-19-2025
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,931,000.00
$2,975,000.00
Revenue This Year
N/A
$2.92
Revenue Next Year
N/A
$57.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.40
$0.59
52 Week High
$19.75
$1.66

Technical Indicators

Market Signals
Indicator
BAFN
ICCM
Relative Strength Index (RSI) 37.72 41.99
Support Level $8.05 $0.67
Resistance Level $8.07 $0.72
Average True Range (ATR) 0.10 0.05
MACD 0.04 0.01
Stochastic Oscillator 24.39 62.50

Price Performance

Historical Comparison
BAFN
ICCM

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: